SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Dispatches from the FT Global Healthcare and biotech conference

Experts: Outsourcing levels could push 80% if CMOs seize future demands

Catering for low value, high volume customers as well as the growing number of firms developing complex drugs will be a big challenge in the era of personalised medicine according to experts speaking at a London conference this week.

UK Hospitals to play part in Gov efforts to speed clinical trial process

UK life sciences minister George Freeman wants hospitals to play more of a role in clinical trials and says accelerating the drug development process in the post block-buster era is key for Big Pharma and patients.

BMS-backed biopharma in pact with preclinical R&D experts

A preclinical biotech backed by Bristol-Myers Squibb is forming a strategic alliance with Synergy Partners R&D Solutions to boost academic discoveries.

Analysis finds 100% SDV has minimal impact on overall data quality

An analysis of clinical trial data by Medidata and industry group TransCelerate BioPharma has found that the value of source document verification (SDV) in a risk-based approach to clinical trial site monitoring is minimal. 

People on the Move

People news: introducing the latest outsourcing appointments

Clinverse, Intertek and inVentiv are among the pharma services companies announcing new staff this week.

New Ricerca CEO remains positive as questions linger over company

As questions continue to be raised over why Ricerca was on the brink of closure and laying off all of its employees, as well as how the company’s new owners and CEO plan to turn it around, one thing is certain: new CEO Clifford Croley is confident.

Dispatches from FT Global Pharmaceutical and Biotechnology conference, London

Quintiles CEO: Change in R&D paradigm must come from Pharma's boardrooms

Vertical integration is inhibiting pharma R&D innovation, according to Quintiles CEO Tom Pike who says executives must be involved in selecting CROs.

Spotlight

Trial transparency's impact opaque say drug and CRO industry experts at PCT in Barcelona

Trial transparency's impact opaque say drug and CRO industry experts at PCT in Barcelona

Making clinical trials more open has pros and cons for CROs and drugmakers according to experts from...

In-house manufacturing ‘trounces’ outsourcing spend, report finds

In-house manufacturing investments ‘trounce’ outsourcing spend, report finds

Biopharma companies are not likely to outsource a larger chunk of their manufacturing than they have in...

Top 7 CROs soon to exceed 50% market share, Parexel CFO says

Top 7 CROs soon to exceed 50% market share, Parexel CFO says

As PRA Health Services goes public this week, nearly all of the top CROs are now public...

China sets new requirements for hospitals running clinical trials

China sets new requirements for hospitals running clinical trials

The Chinese authorities are supplementing their current regulations around clinical trials with new mandates for the hospitals...

INC stock launches up almost 10% as CEO says business as usual
Exclusive interview

INC stock launches up almost 10% as CEO says business as usual

The IPO boom for CROs is kicking off with INC Research’s stock offering, which as of Friday...